Physician profile
Conrad B Ivie
NPI 1497983233
$608,663.25
in general payments reported to CMS, 2019-2025
14 companies · $94K in 2025
The $94K reported for 2025 was more than what 92% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $50K · 2021: $112K · 2022: $104K · 2023: $121K · 2024: $113K · 2025: $94K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $267K · Travel and Lodging: $54K · Food and Beverage: $6,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $266,700.00 |
| Travel and Lodging | $54,059.34 |
| Food and Beverage | $6,787.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $590,073.27 | 2019-2025 | Mako, Insignia, Accolade |
| Medical Device Business Services, INC. | $13,530.01 | 2019 | |
| Arthrex, INC. | $2,989.51 | 2021 | |
| Alpha Orthopedic Systems | $1,090.30 | 2021 | |
| Smoky Mountain Surgical LLC | $210.34 | 2024-2025 | |
| Radius Health, INC. | $202.01 | 2019-2025 | Tymlos |
| Heron Therapeutics, INC. | $170.13 | 2024-2025 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $138.09 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $69.84 | 2019-2025 | Euflexxa |
| Smith+Nephew, INC. | $68.90 | 2019-2025 | Journey II, Real Intelligence, Pico 14 |
| Pacira Therapeutics, INC. | $66.06 | 2019 | |
| Davol INC. | $23.83 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $19.26 | 2023 | |
| Horizon Therapeutics Plc | $11.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conrad Ivie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.